{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:22Z","timestamp":1760956162911,"version":"build-2065373602"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Inovet"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Since the outbreak of bluetongue in Northern Europe in 2006, numerous outbreaks involving several serotypes have been observed. Since 2008, compulsory or voluntary vaccination campaigns with inactivated vaccines have been carried out to eradicate these serotypes. In France, serotypes 8 and 4 have been enzootic since 2017, and currently, the majority of vaccinations take place in the context of animal movements, to comply with the regulations of the importing countries. Several vaccine manufacturers have developed inactivated vaccines against serotypes 4 and 8 (mono or bivalent). In this study, we investigated and compared the serological responses to a booster vaccination with two different bivalent inactivated vaccines (BTVPUR suspension injectable\u00ae 4 + 8, Boehringer Ingelheim or SYVAZUL \u00ae BTV 4 + 8, Biov\u00e9) following a primary vaccination with BTVPUR\u00ae 4 + 8 in the previous year. The results show that using an alternative vaccine for booster vaccination is at least as effective as using the homologous vaccine. Indeed, the antibody response against BTV-8 is higher in the case of a heterologous vaccination and identical for BTV-4. This information could allow more flexibility in the choice of vaccines used for booster vaccination, particularly in cases where homologous vaccines are in short supply or unavailable.<\/jats:p>","DOI":"10.3390\/v14122719","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T07:07:31Z","timestamp":1670224051000},"page":"2719","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serological Responses in Cattle following Booster Vaccination against Serotypes 4 and 8 Bluetongue Virus with Two Bivalent Commercial Inactivated Vaccines"],"prefix":"10.3390","volume":"14","author":[{"given":"Corinne","family":"Sailleau","sequence":"first","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-3235","authenticated-orcid":false,"given":"Lydie","family":"Postic","sequence":"additional","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Chatenet","sequence":"additional","affiliation":[{"name":"Inovet, Orion, 3 rue de Lorraine, 62510 Arques, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Salat","sequence":"additional","affiliation":[{"name":"Commissions Vaches Laiti\u00e8res et Qualit\u00e9 du Lait de la SNGTV, Clinique V\u00e9t\u00e9rinaire de la Haute Auvergne, 15100 Saint Flour, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Turpaud","sequence":"additional","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0669-1394","authenticated-orcid":false,"given":"Benoit","family":"Durand","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Laboratory for Animal Health, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), University Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-2624","authenticated-orcid":false,"given":"Damien","family":"Vitour","sequence":"additional","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6733-8503","authenticated-orcid":false,"given":"St\u00e9phan","family":"Zientara","sequence":"additional","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Br\u00e9ard","sequence":"additional","affiliation":[{"name":"UMR VIROLOGIE, INRAE, \u00c9cole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, ANSES Laboratoire de Sant\u00e9 Animale, Universit\u00e9 Paris-Est, 94700 Maisons-Alfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcpa.2009.04.003","article-title":"The pathology and pathogenesis of bluetongue","volume":"141","author":"Maclachlan","year":"2009","journal-title":"J. Comp. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.theriogenology.2011.07.015","article-title":"Bluetongue virus serotype 8: Abortion and transplacental transmission in cattle in the Burgundy region, France, 2008\u20132009","volume":"77","author":"Zanella","year":"2012","journal-title":"Theriogenology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kundlacz, C., Caignard, G., Sailleau, C., Viarouge, C., Postic, L., Vitour, D., Zientara, S., and Breard, E. (2019). Bluetongue Virus in France: An Illustration of the European and Mediterranean Context since the 2000s. Viruses, 11.","DOI":"10.3390\/v11070672"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cimid.2007.07.006","article-title":"Vaccines against bluetongue in Europe","volume":"31","author":"Savini","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.vaccine.2010.12.105","article-title":"Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats","volume":"29","author":"Breard","year":"2011","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.vaccine.2009.04.056","article-title":"Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep","volume":"27","author":"Eschbaumer","year":"2009","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1016\/j.vaccine.2009.04.072","article-title":"Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions","volume":"27","author":"Gethmann","year":"2009","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/vr.165.13.369","article-title":"Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle","volume":"165","author":"Hamers","year":"2009","journal-title":"Vet.-Rec."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1016\/j.vaccine.2009.09.070","article-title":"Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep","volume":"27","author":"Oura","year":"2009","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tvjl.2010.04.001","article-title":"Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines","volume":"188","author":"Bartram","year":"2011","journal-title":"Vet.-J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Br\u00e9ard, E., Turpaud, M., Beaud, G., Postic, L., Fablet, A., Beer, M., Sailleau, C., Caignard, G., Viarouge, C., and Hoffmann, B. (2021). Development and Validation of an ELISA for the Detection of Bluetongue Virus Serotype 4-Specific Antibodies. Viruses, 13.","DOI":"10.3390\/v13091741"},{"key":"ref_12","unstructured":"R Core Team (2022). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1865-1682.2011.01230.x","article-title":"The presence of bluetongue virus serotype 8 RNA in Belgian cattle since 2008","volume":"58","author":"Garigliany","year":"2011","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/vr.100485","article-title":"Difficulties in the interpretation of bluetongue RT-PCR results in France","volume":"170","author":"Zientara","year":"2012","journal-title":"Vet.-Rec."},{"key":"ref_16","first-page":"157","article-title":"Bluetongue Virus RNA Detection by Real-Time RT-PCR in Post-Vaccination Samples from Cattle","volume":"62","author":"Garigliany","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.vaccine.2009.10.138","article-title":"Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine","volume":"28","author":"Eschbaumer","year":"2009","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1016\/j.vaccine.2010.06.034","article-title":"Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine","volume":"28","author":"Steinrigl","year":"2010","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1128\/JCM.00599-09","article-title":"Real-Time Quantitative Reverse Transcription-PCR Assays Specifically Detecting Bluetongue Virus Serotypes 1, 6, and 8","volume":"47","author":"Hoffmann","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2007.05.014","article-title":"Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1","volume":"145","author":"Shaw","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2006.11.007","article-title":"Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments","volume":"140","author":"Toussaint","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-60761-629-0_7","article-title":"Simultaneous Detection of Bluetongue Virus RNA, Internal Control GAPDH mRNA, and External Control Synthetic RNA by Multiplex Real-Time PCR","volume":"630","author":"Vandenbussche","year":"2010","journal-title":"Methods Mol Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/tbed.12048","article-title":"A One-year Follow-up of Antibody Response in Cattle and Sheep after Vaccination with Serotype 8- and Serotype 1-inactivated BT Vaccines","volume":"61","author":"Zanella","year":"2013","journal-title":"Transbound. Emerg. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/12\/2719\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:34:21Z","timestamp":1760146461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/12\/2719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["v14122719"],"URL":"https:\/\/doi.org\/10.3390\/v14122719","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}